Sample size for a noninferiority clinical trial with time-to-event data in the presence of competing risks

被引:2
作者
Han, Dong [1 ,2 ]
Chen, Zheng [1 ]
Hou, Yawen [3 ]
机构
[1] Southern Med Univ, Sch Publ Hlth, Dept Biostat, Guangdong Prov Key Lab Trop Dis Res, Guangzhou, Guangdong, Peoples R China
[2] Southern Med Univ, Dept Qual Control, Affiliated Hosp 3, Guangzhou, Guangdong, Peoples R China
[3] Jinan Univ, Dept Stat, Coll Econ, Guangzhou, Guangdong, Peoples R China
基金
中国国家自然科学基金;
关键词
Competing risks; Noninferiority clinical trials; sample size; sub-distribution hazard ratio; survival data; END-POINTS; MULTISTATE MODELS; FOLLOW-UP; PITFALLS; CANCER;
D O I
10.1080/10543406.2017.1399897
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The analysis and planning methods for competing risks model have been described in the literature in recent decades, and noninferiority clinical trials are helpful in current pharmaceutical practice. Analytical methods for noninferiority clinical trials in the presence of competing risks (NiCTCR) were investigated by Parpia et al., who indicated that the proportional sub-distribution hazard (SDH) model is appropriate in the context of biological studies. However, the analytical methods of the competing risks model differ from those appropriate for analyzing noninferiority clinical trials with a single outcome; thus, a corresponding method for planning such trials is necessary. A sample size formula for NiCTCR based on the proportional SDH model is presented in this paper. The primary endpoint relies on the SDH ratio. A total of 120 simulations and an example based on a randomized controlled trial verified the empirical performance of the presented formula. The results demonstrate that the empirical power of sample size formulas based on the Weibull distribution for noninferiority clinical trials with competing risks can reach the targeted power.
引用
收藏
页码:797 / 807
页数:11
相关论文
共 22 条
[1]   Competing risks in epidemiology: possibilities and pitfalls [J].
Andersen, Per Kragh ;
Geskus, Ronald B. ;
de Witte, Theo ;
Putter, Hein .
INTERNATIONAL JOURNAL OF EPIDEMIOLOGY, 2012, 41 (03) :861-870
[2]   Interpretability and importance of functionals in competing risks and multistate models [J].
Andersen, Per Kragh ;
Keiding, Niels .
STATISTICS IN MEDICINE, 2012, 31 (11-12) :1074-1088
[3]  
[Anonymous], 2008, BIOMETRICS, DOI DOI 10.1111/J.1541-0420.2008.01138_10.X
[4]  
BEYERSMANN J., 2011, Competing Risks and Multistate Models with R
[5]   Estimating the case fatality rate using a constant cure-death hazard ratio [J].
Chen, Zheng ;
Akazawa, Kohei ;
Nakamura, Tsuyoshi .
LIFETIME DATA ANALYSIS, 2009, 15 (03) :316-329
[6]   Sample size estimation for non-inferiority trials of time-to-event data [J].
Crisp, Adam ;
Curtis, Paula .
PHARMACEUTICAL STATISTICS, 2008, 7 (04) :236-244
[7]   A proportional hazards model for the subdistribution of a competing risk [J].
Fine, JP ;
Gray, RJ .
JOURNAL OF THE AMERICAN STATISTICAL ASSOCIATION, 1999, 94 (446) :496-509
[8]   Sample size calculations in the presence of competing risks [J].
Latouche, A. ;
Porcher, R. .
STATISTICS IN MEDICINE, 2007, 26 (30) :5370-5380
[9]   Sample size formula for proportional hazards modelling of competing risks [J].
Latouche, A ;
Porcher, R ;
Chevret, S .
STATISTICS IN MEDICINE, 2004, 23 (21) :3263-3274
[10]   Competing Risk Regression Models for Epidemiologic Data [J].
Lau, Bryan ;
Cole, Stephen R. ;
Gange, Stephen J. .
AMERICAN JOURNAL OF EPIDEMIOLOGY, 2009, 170 (02) :244-256